DahariLAB
Mathematical/Computational Virology & Medicine
Full Publications
2020
January 2020
Modeling Challenges of Ebola Virus -Host Dynamics during Infection and Treatment
Chertow D.S., et al.
VIRUSES
April 2020
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg
Shekhtman L, et al.
SCIENTIFIC REPORTS
July 2020
Understanding hepatitis B virus dynamics and the antiviral effect of interferon-a treatment in humanized chimeric mice
Canini L., et al.
BIORXIV
September 2020
Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents?
Dahari H., et al.
HEPATOLOGY
April 2020
Sustained Virological Response Following an 11 Day Course of Direct Acting Antiviral Therapy for Hepatitis C Infection
Yardeni D, et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
May 2020
Evaluation of short-course direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: A single-centre, open-label study
Feld J.J., et al.
THE LANCET GASTROENTEROLOGY & HEPATOLOGY
July 2020
HCVMultiscaleFit: A Simulator for Parameter Estimation in Multiscale Models of Hepatitis C Virus Dynamics
Churkin A., et al.
AIP CONFERENCE PROCEEDINGS
October 2020
Re-treatment with direct-acting antivirals policy is needed to eliminate Hepatitis C among persons who inject drugs
Tatara E., et al.
ARXIV
August 2020
Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics
Churkin A., et al.
MATHEMATICS SPECIAL ISSUE MATHEMATICAL MODELING IN BIOMEDICINE
April 2020
Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration
Dasgupta S, et al.
JOURNAL OF INFECTIOUS DISEASES
June 2020
Modeling based response guided therapy in subjects with recent hepatitis C infection
Gorstein E., et al.
ANTIVIRAL RESEARCH
July 2020
Understanding the antiviral effects of RNAi-based therapy on chronic hepatitis B infection
Kadelka S., et al.
BIORXIV
October 2020
Efficacy and Safety of Modeling-Based Response Guided Therapy with Direct Acting Anti-Viral Agents for Treatment Optimization in Chronic Hepatitis C Infection- A Pilot Study
Etzion O., et al.
SCIENTIFIC REPORTS
August 2020
Modeling hepatitis C virus kinetics during liver transplantation highlights the role of the liver in virus clearance
Shekhtman L., et al.
MEDRXIV
2019
January 2020
Modeling Challenges of Ebola Virus -Host Dynamics during Infection and Treatment
Chertow D.S., et al.
VIRUSES
April 2020
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg
Shekhtman L, et al.
SCIENTIFIC REPORTS
July 2020
Understanding hepatitis B virus dynamics and the antiviral effect of interferon-a treatment in humanized chimeric mice
Canini L., et al.
BIORXIV
September 2020
Letter to the Editor: Examining HBV RNA kinetics during NA treatment - are NA multifunctional antiviral agents?
Dahari H., et al.
HEPATOLOGY
April 2020
Sustained Virological Response Following an 11 Day Course of Direct Acting Antiviral Therapy for Hepatitis C Infection
Yardeni D, et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
May 2020
Evaluation of short-course direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: A single-centre, open-label study
Feld J.J., et al.
THE LANCET GASTROENTEROLOGY & HEPATOLOGY
July 2020
HCVMultiscaleFit: A Simulator for Parameter Estimation in Multiscale Models of Hepatitis C Virus Dynamics
Churkin A., et al.
AIP CONFERENCE PROCEEDINGS
October 2020
Re-treatment with direct-acting antivirals policy is needed to eliminate Hepatitis C among persons who inject drugs
Tatara E., et al.
ARXIV
August 2020
Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics
Churkin A., et al.
MATHEMATICS SPECIAL ISSUE MATHEMATICAL MODELING IN BIOMEDICINE
April 2020
Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration
Dasgupta S, et al.
JOURNAL OF INFECTIOUS DISEASES
June 2020
Modeling based response guided therapy in subjects with recent hepatitis C infection
Gorstein E., et al.
ANTIVIRAL RESEARCH
July 2020
Understanding the antiviral effects of RNAi-based therapy on chronic hepatitis B infection
Kadelka S., et al.
BIORXIV
October 2020
Efficacy and Safety of Modeling-Based Response Guided Therapy with Direct Acting Anti-Viral Agents for Treatment Optimization in Chronic Hepatitis C Infection- A Pilot Study
Etzion O., et al.
SCIENTIFIC REPORTS
August 2020
Modeling hepatitis C virus kinetics during liver transplantation highlights the role of the liver in virus clearance
Shekhtman L., et al.
MEDRXIV